查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654304

全球豬隻疫苗市場：市場規模、佔有率、趨勢分析（按產品、類型、給藥途徑和地區）、細分市場預測（2025-2030 年）

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

豬疫苗市場的成長與趨勢：

根據 Grand View Research 的新報告，到 2030 年全球豬隻疫苗市場規模預計將達到 24.1 億美元。

預計 2025 年至 2030 年期間該市場的複合年成長率為 5.51%。豬隻病患病率和發病率的不斷上升、人們對通用感染疾病的日益擔憂以及養豬場生物安全措施的加強是推動市場成長的一些主要因素。此外，政府和獸醫組織為傳播疾病意識和支持疫苗接種所做的努力將進一步推動預測期內的市場成長。

新冠肺炎疫情對主要企業的豬疫苗業務產生了直接或間接的影響，初期業績表現不佳。疫情對各類生產和供應鏈瓶頸的影響，導致必要原料和活性成分供應延遲，部分研發活動延後。然而，近期多地區同時爆發的非洲豬瘟疫情為豬疫苗生產企業帶來了龐大的需求。 2020年，世界動物衛生組織通報亞洲共發生9,928例非洲豬瘟病例，其次是歐洲，共報告4,271例。因此，政府考慮到這種情況，透過放鬆管制來支持豬疫苗的分發。

此外，抗生素抗藥性已成為全球農業和獸醫學領域日益關注的問題。因此，一些國家禁止在畜牧業生產中使用抗生素，包括作為預防和治療手段。該法強制要求養豬場採用無抗生素的方法來預防疾病，例如接種疫苗。此外，主要企業不斷增加對開發用於更好診斷的先進產品的投資可能會促進市場的發展。例如，2020 年 5 月，印度免疫學有限公司 (Indian Immunologicals Ltd.) 推出了一種以「Raksha Class」為品牌的豬瘟疫苗，該疫苗基於與印度巴雷利獸醫研究所合作開發的專有細胞培養技術。

市場的主要企業正在採取各種策略性舉措，企業合併、合作、產品發布等，以保持市場競爭力。例如，2022年3月，Ceva推出了母豬疫苗，這是一款含有七種抗原的疫苗，用於治療新生兒腹瀉。

豬疫苗市場：分析概述

  • 去活化疫苗佔市場主導地位，2024 年銷售額佔有率最大，為 52.03%。這是因為它們比活病毒疫苗具有易於取得、成本低和穩定等優勢。
  • 根據疾病類型，PRRS（豬生殖與呼吸症候群）在 2024 年佔據市場主導地位，收入佔有率最大，為 14.26%。
  • 根據給藥途徑，注射劑在 2024 年佔據市場最大收益佔有率，達到 75.79%，這得益於其在為豬提供針對主要疾病的長期保護方面的效率和效果。
  • 按分銷管道分類，醫院/診所藥房在 2024 年佔據最大的銷售佔有率。這是因為直接的終端使用者參與、即時疫苗接種服務和全面的醫療保健解決方案確保了及時分發疫苗和有效控制畜牧業的疾病。
  • 2024 年北美佔據豬隻疫苗市場最大的銷售佔有率，為 38.46%。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章 豬疫苗市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 豬疫苗市場：分析工具
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析
    • 政局
    • 產品平臺分析
    • COVID-19 分析
    • 主要國家生豬數量預估（2018-2024）

第 4 章 豬隻疫苗市場：依產品分類的業務分析

  • 按產品市場佔有率（2024 年和 2030 年）
  • 產品儀表板
  • 依產品分類的市場規模預測及趨勢分析（2018-2030）
  • 修正/阻尼
  • 去活化（殺死）
  • 其他

第 5 章豬疫苗市場：依疾病類型進行的商業分析

  • 按疾病類型分類的市場佔有率（2024 年和 2030 年）
  • 疾病類型儀表板
  • 依疾病類型分類的市場規模預測及趨勢分析（2018-2030 年）
  • 豬流感
  • 豬霍亂
  • 豬細小病毒
  • 豬環狀病毒2 型
  • M.Hyo
  • 肺炎放線桿菌
  • 抗逆轉錄病毒藥物
  • 口蹄疫
  • 偽狂犬病
  • PEDV

6. 豬隻疫苗市場：依給藥途徑進行的業務分析

  • 按管理途徑分類的市場佔有率（2024 年和 2030 年）
  • 管理路線儀表板
  • 依管理途徑分類的市場規模預測及趨勢分析（2018-2030 年）
  • 注射
  • 鼻腔
  • 口服

第 7 章豬疫苗市場：按通路分類的業務分析

  • 按分銷管道分類的市場佔有率（2024 年和 2030 年）
  • 分銷通路儀表板
  • 按分銷管道分類的市場規模預測及趨勢分析（2018-2030 年）
  • 零售
  • 電子商務
  • 醫院/診所藥房

第 8 章 豬隻疫苗市場：區域估計與趨勢分析（依產品、疾病類型、給藥途徑及通路）

  • 各地區市場佔有率（2024 年及 2030 年）
  • 區域市場儀表板
  • 各地區市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非

第9章 競爭格局

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Merck &Co., Inc.
    • Ceva
    • Zoetis
    • Boehringer Ingelheim GmbH
    • Elanco
    • Indian Immunologicals Ltd.
    • BiogenesisBago
    • Phibro Animal Health
    • KM Biologics
    • HIPRA
    • Virbac

第10章 重點

Product Code: GVR-4-68039-728-0

Swine Vaccines Market Growth & Trends:

The global swine vaccines market size is expected to reach USD 2.41 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a lucrative CAGR of 5.51% from 2025 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player's swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company's growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name 'Raksha Class', a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights:

  • The Inactivated (Killed) segment led the market with the largest revenue share of 52.03% in 2024. This is attributed to its easy availability, low cost, and stability advantages over live-attenuated vaccines.
  • Based on disease type, the PRRS (Porcine Reproductive and Respiratory Syndrome) led the market with the largest revenue share of 14.26% in 2024.
  • Based on route of administration, the injectable segment led the market with the largest revenue share of 75.79% in 2024, due to its efficiency and effectiveness in providing long-lasting protection against major diseases in pigs.
  • Based on distribution channel, the hospital/clinic pharmacies segment accounted for the largest revenue share in 2024, due to their direct engagement with end-users, immediate vaccination services, and comprehensive healthcare solutions, ensuring timely vaccine distribution and effective disease management in the livestock sector.
  • North America dominated the swine vaccines market with the largest revenue share of 38.46% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Type
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Swine Vaccines Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising concern about zoonoses & strengthening biosecurity
      • 3.2.1.2. Vaccines act as an alternative to antibiotics
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Supply bans on live pigs and pork products
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Political Landscape
      • 3.3.3.1. Economic Landscape
      • 3.3.3.2. Social Landscape
      • 3.3.3.3. Technology Landscape
      • 3.3.3.4. Legal Landscape
      • 3.3.3.5. Environmental Landscape
      • 3.3.3.6. Regulatory Landscape
    • 3.3.4. Product Pipeline Analysis
    • 3.3.5. Covid-19 Analysis
    • 3.3.6. Estimated Pig population by key countries, 2018 to 2024

Chapter 4. Swine Vaccines Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Modified/Attenuated Live
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Inactivated (Killed)
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Swine Vaccines Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2030
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2018 to 2030 (USD Million)
  • 5.4. Swine Influenza
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Classical Swine Fever
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Porcine Parvovirus
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Porcine Circovirus Type 2
    • 5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. M.Hyo
    • 5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Actinobacillus Pleuropneumonia
    • 5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. PRRS
    • 5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.11. Foot & Mouth Disease
    • 5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.12. Pseudorabies
    • 5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.13. PEDV
    • 5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Swine Vaccines Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Injectables
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Oral
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Swine Vaccines Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Retail
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Hospital/Clinic Pharmacies
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Swine Vaccines Market: Regional Estimates & Trend Analysis by Product, Disease Type, Route of Administration, and Distribution Channel

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Mexico swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Norway swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Denmark swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. South Korea swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Australia swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Thailand swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Argentina swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Merck & Co., Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Ceva
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Zoetis
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Boehringer Ingelheim GmbH
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Elanco
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Indian Immunologicals Ltd.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. BiogenesisBago
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Phibro Animal Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. KM Biologics
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HIPRA
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Virbac
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives

Chapter 10. Key Takeaways

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 5 Global Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 Global Swine Vaccines Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 11 North America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 North America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 U.S. Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Mexico Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Mexico Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 Europe Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Europe Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Europe Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 UK Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 36 UK Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 UK Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 France Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 France Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 40 France Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 France Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Italy Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 44 Italy Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Italy Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Spain Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 48 Spain Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Sweden Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Norway Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 60 Norway Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 China Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 69 China Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 China Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 Japan Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 73 Japan Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 India Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 India Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 77 India Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 India Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Korea Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Korea Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Australia Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 85 Australia Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Australia Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Thailand Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Thailand Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Latin America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Latin America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Brazil Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 98 Brazil Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Brazil Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 Argentina Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 South Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 South Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Swine Vaccines Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Swine Vaccines Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Swine Vaccines Market, for Modified/Attenuated Live, 2018 - 2030 (USD Million)
  • Fig. 16 Global Swine Vaccines Market, for Inactivated (Killed), 2018 - 2030 (USD Million)
  • Fig. 17 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 18 Global Swine Vaccines Market, for Disease Type, 2018 - 2030 (USD Million)
  • Fig. 19 Global Swine Vaccines Market, for Swine Influenza, 2018 - 2030 (USD Million)
  • Fig. 20 Global Swine Vaccines Market, for Classical Swine Fever, 2018 - 2030 (USD Million)
  • Fig. 21 Global Swine Vaccines Market, for Porcine Parvovirus, 2018 - 2030 (USD Million)
  • Fig. 22 Global Swine Vaccines Market, for Porcine Circovirus Type 2, 2018 - 2030 (USD Million)
  • Fig. 23 Global Swine Vaccines Market, for M.Hyo, 2018 - 2030 (USD Million)
  • Fig. 24 Global Swine Vaccines Market, for Actinobacillus Pleuropneumonia, 2018 - 2030 (USD Million)
  • Fig. 25 Global Swine Vaccines Market, for PRRS, 2018 - 2030 (USD Million)
  • Fig. 26 Global Swine Vaccines Market, for Foot & Mouth Disease, 2018 - 2030 (USD Million)
  • Fig. 27 Global Swine Vaccines Market, for Pseudorabies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Swine Vaccines Market, for PEDV, 2018 - 2030 (USD Million)
  • Fig. 29 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Swine Vaccines Market, for Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 31 Global Swine Vaccines Market, for Injectables, 2018 - 2030 (USD Million)
  • Fig. 32 Global Swine Vaccines Market, for Intranasal, 2018 - 2030 (USD Million)
  • Fig. 33 Global Swine Vaccines Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 34 Global Swine Vaccines Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 35 Global Swine Vaccines Market, for Retail, 2018 - 2030 (USD Million)
  • Fig. 36 Global Swine Vaccines Market, for E-Commerce, 2018 - 2030 (USD Million)
  • Fig. 37 Global Swine Vaccines Market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Outlook, 2024 & 2030
  • Fig. 39 North America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 64 Company categorization
  • Fig. 65 Company market position analysis
  • Fig. 66 Strategic framework